Immunyfit: A revolutionary product and platform designed to transform personalized healthcare through advanced systems biology and AI-driven insights. Immunyfit integrates multi-omics data, lifestyle factors, and expert systems to predict autoimmune and gut-immune disorders, providing personalized recommendations for better health outcomes.
________________________________________
Overview
At the core of Immunyfit is a deep understanding of general health, including symptoms, triggers, and diagnostics. We leverage biomarkers, genetics, multi-omics data, and lifestyle factors to create a comprehensive health profile. By analysing this data alongside our scientific knowledge base, our algorithms predict autoimmune and gut-immune disorders at the biomarker and pathway levels. This enables us to provide both generic and personalized suggestions for individuals and populations.
________________________________________
Immunyfit Product & Platform
Immunyfit is more than just a product—it’s a comprehensive platform and expert system. It offers disorder assessment with physiological interpretation, evaluates the impact of lifestyle factors, and categorizes individuals among their peers based on gender, age, and disorder profiles. The platform provides personalized recommendations for supplements, natural foods, and lifestyle adjustments, all powered by systems biology-based AI.
________________________________________
Platform Strengths
Our platform’s strengths lie in its standardize
Startup Description
Immunyfit Healthtech is an investigative physiology platform rooted in systems biology AI and structured scientific knowledge. It delivers personalized, digital, and data-driven assessments and management for autoimmune and gut-immune disorders.
Autoimmune disorders have doubled in prevalence over the past decade, with 20 million patients in India and affecting 3% of the global population currently. Over 60% of patients remain undiagnosed or misdiagnosed due to low awareness, inadequate doctor-patient ratios, and deteriorating environmental and mental stress factors. This complexity strains patients and the healthcare system, with projections indicating that it will impact 5% of the population by 2030.
Our advanced methodologies—predictive analytics, digital biomarkers, healthcare screening, real-time health tracking and remote monitoring, multiomics, and genomics—facilitate early detection, assessment, and evidence-based management and supports patients, doctors, hospitals, and drug research companies achieve better health outcomes.
We are among the first globally to use Biology-First AI for the assessment of autoimmune and gut-immune disorders. Our innovation provides a global competitive advantage in disorder predictive analytics.
Our vision is to drive adoption through patient subscriptions and collaborations with doctors and hospitals, establishing a strong domestic presence before expanding overseas, with a primary focus on Asia and North America.
Product Screenshots
Business Model
Revenue Model & Growth
• Subscription-based platform for doctors, hospitals, and patients.
• Revenue potential includes clinical and drug research using assessment data.
Customers
based in
North America, Middle East & North Africa, India, Southeast Asia, South Asia
Business
Modal Type
SaaS
Type of
Sales
B2B2C
Competitors
Well Theory, Rupa Health, Oshi Health, Alia Health, and Parsley Health are the major global competitors
Teams
Sudeep Suru
Co-Founder
Dr KV Venkatesh
Board Member & Chief
Tell us a bit about how founding team knows
each other.
Our team is headed by a Systems Biology scientist with 20 years of experience in the field, as well as by a multiple autoimmune patient with close to 19 years of experience navigating treatments across various modalities. The founding team identifies gaps both from the patient’s perspective and from the scientific understanding of these disorders. Our team consists of a group of scientists who deeply understand the disorders deeply.
Why did you decide to start this
company?
Immunyfit Healthtech was started to address a critical gap in the assessment and management of autoimmune diseases, particularly focusing on the gut-immune axis.
Are all the founders full-time on this
project?
Yes
Looking for an
opportunity to invest in companies
like Immunyfit Healthtech Pvt Ltd?
